Grail GRAL
NASDAQ GRAL
$117.57 -17.89 (-13.20%)
As of: Oct 16, 2026 · 3:59 PM EDT

Grail (GRAL) Price to Sales (2024 - 2026)

Updated

Grail's (GRAL) Price to Sales stood at 19.40 in Q2 2026, up 40.5% from 13.80 a year earlier and up 31.7% from the prior quarter.

Analysis

Grail (GRAL) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Grail's Price to Sales came in at 23.46, up 386.9% from FY2024.

  • Across earlier years, Price to Sales came in at 4.82 in FY2024.
  • The Q2 2026 figure is the highest quarterly Price to Sales in data going back to Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.89 Bn 96.90 Bn -
2 Natera 56.39 Bn 52.08 Bn 485.19 Mn
3 Quest Diagnostics 26.08 Bn 24.21 Bn 1.03 Bn
4 Labcorp Holdings 26.01 Bn 23.76 Bn 1.11 Bn
5 Tenet Healthcare 22.37 Bn 11.38 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.90 Bn 4.86 Bn 1.52 Bn
8 Encompass Health 12.62 Bn 12.28 Bn -
9 BrightSpring Health Services 12.53 Bn 10.86 Bn 492.75 Mn
10 Grail 5.08 Bn 1.95 Bn 20.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.40
Mar 31, 2026 14.73
Sep 30, 2025 15.08
Jun 30, 2025 13.80
Mar 31, 2025 6.90
Dec 31, 2024 4.82
Sep 30, 2024 2.54
Jun 30, 2024 2.77
API Access

Grail Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=GRAL&period=max&api_key=YOUR_API_KEY